Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-03-01
2011-03-01
Habte, Kahsay T (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S351000, C546S268100, C546S300000
Reexamination Certificate
active
07897622
ABSTRACT:
Compounds of formula I:wherein X, R2, R3, R5and R6are defined herein, are useful as inhibitors of the hepatitis C virus NS5B polymerase.
REFERENCES:
patent: 7112600 (2006-09-01), Hashimoto et al.
patent: 2004/0082635 (2004-04-01), Hashimoto et al.
patent: 1 688 420 (2006-08-01), None
patent: 99/07733 (1999-02-01), None
patent: 99/07734 (1999-02-01), None
patent: 00/09543 (2000-02-01), None
patent: 00/09558 (2000-02-01), None
patent: 00/59929 (2000-10-01), None
patent: 01/47883 (2001-07-01), None
patent: 01/77113 (2001-10-01), None
patent: 01/81325 (2001-11-01), None
patent: 02/04425 (2002-01-01), None
patent: 02/08187 (2002-01-01), None
patent: 02/08198 (2002-01-01), None
patent: 02/08244 (2002-01-01), None
patent: 02/08256 (2002-01-01), None
patent: 02/48172 (2002-06-01), None
patent: 02/060926 (2002-08-01), None
patent: 03/000254 (2003-01-01), None
patent: 03/004458 (2003-01-01), None
patent: 03/007945 (2003-01-01), None
patent: 03/010140 (2003-02-01), None
patent: 03/010141 (2003-02-01), None
patent: 03/026587 (2003-04-01), None
patent: 03/053349 (2003-07-01), None
patent: 03/062228 (2003-07-01), None
patent: 03/062265 (2003-07-01), None
patent: 03/064416 (2003-08-01), None
patent: 03/064455 (2003-08-01), None
patent: 03/064456 (2003-08-01), None
patent: 03/093316 (2003-12-01), None
patent: 03/099274 (2003-12-01), None
patent: 03/101993 (2003-12-01), None
patent: 2004/030670 (2004-04-01), None
patent: 2004/032827 (2004-04-01), None
patent: 2004/037855 (2004-05-01), None
patent: 2004-039833 (2004-05-01), None
patent: 2004/043339 (2004-05-01), None
patent: 2004/064925 (2004-08-01), None
patent: 2004/065367 (2004-08-01), None
patent: 2004/072243 (2004-08-01), None
patent: 2004/087714 (2004-10-01), None
patent: 2004/093798 (2004-11-01), None
patent: 2004/094452 (2004-11-01), None
patent: 2004/101602 (2004-11-01), None
patent: 2004/101605 (2004-11-01), None
patent: 2004/103996 (2004-12-01), None
patent: 2004/113365 (2004-12-01), None
patent: 2005/010029 (2005-02-01), None
patent: 2005/014543 (2005-02-01), None
patent: 2205/012288 (2005-02-01), None
patent: 2005/021584 (2005-03-01), None
patent: 2005/028501 (2005-03-01), None
patent: 2005/030796 (2005-04-01), None
patent: 2005/037214 (2005-04-01), None
patent: 2005/046712 (2005-05-01), None
patent: 2005/049622 (2005-06-01), None
patent: 2005/051410 (2005-06-01), None
patent: 2005/051980 (2005-06-01), None
patent: 2005/054430 (2005-06-01), None
patent: 2005/058821 (2005-06-01), None
patent: 2005/070955 (2005-08-01), None
patent: 2005/080388 (2005-09-01), None
patent: 2005/085197 (2005-09-01), None
patent: 2005/085242 (2005-09-01), None
patent: 2005/085275 (2005-09-01), None
patent: 2005/087721 (2005-09-01), None
patent: 2005/087725 (2005-09-01), None
patent: 2005/087730 (2005-09-01), None
patent: 2005/087731 (2005-09-01), None
patent: 2005/107745 (2005-11-01), None
patent: 2005/113581 (2005-12-01), None
patent: 2005/121132 (2005-12-01), None
patent: 2006/000085 (2006-01-01), None
patent: 2006/007693 (2006-01-01), None
patent: 2006/007700 (2006-01-01), None
patent: 2006/007708 (2006-01-01), None
A.F. Abdel-Magid, et al., “Reductive Amination of Aldehydes and Ketones with Sodium Triacetoxyborohydride. Studies on Direct and Indirect Reductive Amination Procedures”, J. Org. Chem., 1996, vol. 61, p. 3849.
S. M. Berge, et al., “Pharmaceutical Salts”, Journal of Pharmaceutical Sciences, 1977, vol. 66, No. 1, p. 1.
E. Buck, et al., “Preparation of 1-Methoxy-2-(4-Methoxyphenoxy) Benzene”, Org. Syntheses, 2005, vol. 82, p. 69.
R. Hemalatha, et al., “QSAR Analysis of 5-substituted-2-Benzoylaminobenzoic acids as PPAR Modulator”, E-Journal of Chemistry, 2004, vol. 1, No. 5, p. 243-250S.
E. J. Hennessy, et al., “A General and Mild Copper-Catalyzed Arylation of Diethyl Malonate”, Organic Letters, 2002, vol. 4, No. 2, p. 269.
A. A. Kolykhalov, et al., “Hepatitis C Virus-Encoded Enzymatic Activities and Conserved RNA Elements in the 3′ Nontranslated Region are Essential for Virus Replication in Vivo”, J. Virology, 2000, vol. 74, No. 4, p. 2046.
G. McKercher, et al., “Specific inhibitors of HCV polymerase identified using an NS5B with lower affinity for template/primer substrate”, Nucleic Acids Res., 2004, vol. 32, No. 2, p. 422.
T. Östberg, et al., “A New Class of Peroxisome Proliferator-activated Receptor Agonists with a novel Binding Epitope Shows Antidiabetic Effects”, J. Biological Chemistry, 2004, vol. 279, No. 39, p. 41124.
W. C. Still, et al., “Rapid Chromatographic Technique for Preparative Separations with Moderate Resolution”, J. Org. Chem., 1978, vol. 43, No. 14, p. 2923.
K. Takagi, “Synthesis of Aromatic Thiols from Aryl Iodides and Thiourea by Means of Nickel Catalyst”, Chemistry Letters, 1985, p. 1307.
K. Tanaka, et al., “Synthesis and Reaction of 5-Amino-3-trifluoromethylisoxazole and—pyrazole-4-carboxylic Acids”, J. Heterocyclic Chem., 1986, vol. 23, p. 1535.
M. Thor, et al., “Synthesis and Pharmacological Evaluation of a New Class of Peroxisome Proliferator-Activated Receptor Modulators”, Bioorganic and Medicinal Chemistry Letters, 2002, vol. 12, p. 3565.
International Search Report PCT/CA2007/001363, Mailed Oct. 29, 2007.
Beaulieu Pierre
Coulombe René
Fazal Gulrez
Goulet Sylvie
Poirier Martin
Boehringer Ingelheim International GmbH
Dow David A.
Habte Kahsay T
Morris Michael P.
LandOfFree
Viral polymerase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Viral polymerase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Viral polymerase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2749545